Caricamento...
Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants
BACKGROUND: Retinopathy of prematurity (ROP) is a vision‐threatening disease of preterm neonates. The use of beta‐adrenergic blocking agents (beta‐blockers), which modulate the vasoproliferative retinal process, may reduce the progression of ROP or even reverse established ROP. OBJECTIVES: To determ...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494413/ https://ncbi.nlm.nih.gov/pubmed/29499081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011893.pub2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|